Gablofen

Gablofen is a brand name of baclofen, approved by the FDA in the following formulation(s):

GABLOFEN (baclofen - injectable; intrathecal)

• 
  Manufacturer: CNS THERAPS INC
  
  Approval date: November 19, 2010
  
  Strength(s): 0.05MG/ML ^[AP], 0.5MG/ML ^[AP], 2MG/ML ^[AP]

Has a generic version of Gablofen been approved?

No. There is currently no therapeutically equivalent version of Gablofen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gablofen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Gablofen.

See also...

• Gablofen Consumer Information (Drugs.com)
• Gablofen Consumer Information (Wolters Kluwer)
• Gablofen Advanced Consumer Information (Micromedex)
• Baclofen Consumer Information (Drugs.com)
• Baclofen Consumer Information (Wolters Kluwer)
• Baclofen Tablets Consumer Information (Wolters Kluwer)
• Baclofen Consumer Information (Cerner Multum)
• Baclofen Advanced Consumer Information (Micromedex)
• Baclofen Intrathecal Advanced Consumer Information (Micromedex)
• Baclofen AHFS DI Monographs (ASHP)